Understanding Endosarcode: Rare Cancer of the Uterine Lining

Endosarcode is a type of sarcoma that originates in the endometrium, which is the lining of the uterus. It is a rare form of cancer that accounts for less than 1% of all uterine cancers. Endosarcode typically affects postmenopausal women and is more common in those with a history of estrogen exposure.

The symptoms of endosarcode are non-specific and can include abnormal vaginal bleeding, pelvic pain, and a mass in the pelvis. The diagnosis of endosarcode is based on a combination of imaging studies such as ultrasound, MRI, and CT scans, along with a biopsy to confirm the presence of cancer cells.

Treatment for endosarcode usually involves surgery to remove the tumor, followed by radiation therapy and/or chemotherapy to kill any remaining cancer cells. The prognosis for endosarcode is generally poor, with a five-year survival rate of around 30%. However, the specific prognosis can vary depending on the stage and aggressiveness of the cancer, as well as the effectiveness of the treatment.